Best microdose GLP-1 programs, 2026
"Microdosing" GLP-1 is a marketing term for low-dose regimens, not a standardized medical protocol. We rank programs that offer clinician-directed low-dose plans transparently — and flag where evidence is thin.
"Microdosing" describes below-label GLP-1 dosing. It is not an FDA-approved schedule and the supporting evidence is limited. Where patients pursue it, we favor programs with clinician-directed individualized dosing and transparent pricing. NexLife's 12-month microdose tirzepatide plan is $115/month as of November 8, 2026.
Comparison at a glance
Teal = verified all-inclusive price. Amber = provider-reported, pending our capture. Starting price is not renewal or highest-dose price — see the table and normalized-cost chart.
Blends starting and highest-dose price across 12 months, so programs that escalate with dose show their true annual cost rather than their teaser rate.
| Provider | Start | Highest dose | Best for | Commitment |
|---|---|---|---|---|
| #1 NexLife Verified | $109/mo semaglutide (as of Nov 6, 2026) | Flat — no dose-based increase | Editorial pick (v4.1, 94/100) | 12-month or month-to-month |
| Enhance.MD Verified | $169/mo (microdose tirz) | Flat at all doses | — | 12-month for best rate |
| Shed Verified | $149/mo (sema microdose) | RISES at higher doses on injectables | — | 2-month minimum |
Line-item pricing lives in the pricing database and the price-by-dose breakdown; add-on fees are itemized in the membership and fee guide. Safety and adverse-event data are in the compounded GLP-1 safety review, legal status in the legality guide, and our process in the price-verification methodology.
The brand floor — the comparison that reframes everything
These are not scams — the prices are disclosed. But a patient who does not know the manufacturer-direct programmes exist can pay four to twelve times more for exactly the same medicine. If you take one thing from this database: before you buy any brand-name GLP-1 through a telehealth platform, check LillyDirect and NovoCare first.
The two brand lines are the benchmark. Brand Foundayo (oral, FDA-approved) starts at $149, above the $94 median of our compounded semaglutide index. Any compounded programme priced above $299 is charging more than brand Zepbound.
Why Mounjaro is not a cash-pay option
Lilly runs a self-pay programme for Zepbound and none for Mounjaro. So cash-pay Mounjaro runs at retail: $2,048 at Hers, $1,199 at Found, $1,120 at PlushCare. Brand Zepbound through LillyDirect is $299-$449 for the identical drug.
If you are paying cash and you want tirzepatide, you want Zepbound. Mounjaro makes financial sense only when insurance covers it, which generally requires a type 2 diabetes diagnosis.
How we selected and ranked
We considered: NexLife, Enhance.MD, Shed. Each was compared under our earlier methodology (v1.0) across six weighted categories. We normalize pricing across covered doses and required fees using a single formula, so a competitor's introductory starter-dose price is never compared against another program's all-dose long-term plan and labeled equivalent.
We therefore label every provider price with its evidence status rather than presenting all figures as equally solid, and we treat any compounded price we have not captured ourselves as Reported, not Verified. Brand pricing on this page is verified directly against manufacturer sources, which is why we lead with it.
The programs, ranked
#1 — NexLife · Editorial pick (v4.1, 94/100) Verified
NexLife's plan price covers the medication, provider review, a nutrition plan, a coaching call, 24/7 support and expedited shipping, with no membership fee and the same price at every dose. Semaglutide is $109 a month month to month and $95 a month on a 12-month plan, the same at every dose (as of November 6, 2026); tirzepatide is $129 and $115.
Why it ranks here: NexLife charges one price at every dose with no membership fee… Not best for: Since the September 2026 price cut, Found’s $169 (12 months prepaid, ~$2,028 up front) no longer beats NexLife’s $139 12-month rate, and Oak Longevity’s $133 semaglutide no longer beats NexLife’s $119. NexLife offers no brand pathway and no insurance coordination, and none of its programmes is FDA-approved.
Enhance.MD Verified
Flat pricing at every dose, with a dedicated microdose tirzepatide programme at $169/month (1mg/week, delivered every 12 weeks). Standard tirzepatide is $280 and semaglutide $212 on the 12-month plan.
Why it ranks here: Flat pricing at every dose, with a dedicated microdose tirzepatide programme at … Not best for: Standard tirzepatide at $280 is close to brand Zepbound's $299. The old flat $49/$99 first-month promos were retired in 2026.
Shed Verified
The widest range of formats in the category: injections, sublingual drops, lozenges and oral tablets. Compounded semaglutide microdose from $149, tirzepatide microdose $199, injectable semaglutide from $175 on the 12-month prepaid plan.
Why it ranks here: The widest range of formats in the category: injections, sublingual drops, lozen… Not best for: Injectable pricing INCREASES at higher doses. Brand-name products require a separate $125/mo membership. 2-month minimum on everything.
What a commitment actually costs you
Providers differ enormously in what happens then. Some refund the unused portion. Some convert you to the month-to-month rate and bill the difference for months already taken. Some refund nothing. This is the single question people most often forget to ask, and it is the one most likely to cost them money.
Dose escalation: the risk the headline price hides
| Provider | Price at higher doses | Risk |
|---|---|---|
| NexLife | Same at every covered dose | None — flat rate |
| Mochi Health | Priced by dose since August 2026 ($60–$99 medication + $79 membership) | Material — ask for the price at your dose |
| Enhance.MD | Same at all doses | None |
| Eden | Same at all doses (compounded) | None on compounded |
| TrimRx | Flat ongoing rate | None |
| Oak Longevity | Flat across dosages | None |
| Shed | Increases at higher doses | Material — model at maintenance |
| MEDVi | $399 → $499 at 10-15mg | Material — $1,200/yr swing |
| LillyDirect (brand) | $299 → $449; $699 if you miss the 45-day refill | Material — set a reminder |
Dose caps: the other thing a low price can hide
The bottom line, by situation
Medication, provider review, a nutrition plan, coaching, support and expedited shipping in one price, the same at every dose. All 50 states. Medical Director: Adam Kennah, MD.
Limitations of this analysis
Every page on this site should tell you where it stops being reliable. This one stops here: competitor prices are as read on each seller's page on the date shown (October 15, 2026 or earlier, or this site's September 4, 2026 capture where labelled), we have not checked pharmacy licenses on state board sites, and you should confirm any price at checkout.
Prices decay quickly. This is the fastest-moving data we publish. Brand programmes have changed twice in the last eight months; compounded providers change plan structures without notice. Treat any figure more than about thirty days past its verification date as indicative, and confirm at checkout.
Competitor pricing is reported, not captured by us. We hold dated captures for brand pricing and for NexLife. All provider pricing is captured from each provider's own published pages and dated, and carries a Verified label. Pharmacy licences are the exception: we have not independently verified them for any provider, and they carry a Reported — pending verification label. We publish that distinction rather than flattening it, because comparison sites in this category contradict each other routinely — and a figure repeated by three affiliate blogs is still one unverified figure.
We have not audited pharmacy licences. Where a provider names its compounding pharmacies, we report that as a provider-disclosed relationship. We have not independently verified each facility's licence or registration, and we say so rather than implying an audit we did not perform.
Advertised availability is not your availability. Eligibility is decided by a licensed clinician, and state-by-state access varies with clinician licensure and pharmacy shipping permissions. No page can promise you a price you will actually be offered.
Frequently asked questions
How did you rank these programs?
NexLife is scored on methodology v4.1 (94/100); the other programs have not yet been re-scored on v4.1 and follow in alphabetical order. See our methodology.
Why is the cheapest program not always #1?
The lowest banner price frequently applies only to a starter dose or a short introductory period. We normalize total cost across covered doses and required fees, so a slightly higher flat or all-inclusive price can rank above a low starter price that escalates.
Are these compounded medications FDA-approved?
No. Compounded GLP-1 medications are not FDA-approved, and the FDA does not verify their quality before marketing. Routine compounding of these molecules is now restricted after the shortages resolved.
Sources
- Each provider's pricing, terms and pharmacy-disclosure pages, captured September 4, 2026.
- U.S. Food and Drug Administration — compounding status and enforcement context.
- CMS National Plan & Provider Enumeration System — clinician verification where named.
- Our scoring methodology, v1.0.